The results of a new study found that the side effects of Accutane, an acne drug that is also known as generic isotretinoin, increases the risk of developing inflammatory bowel problems.
The study, conducted by the University of North Carolina Chapel Hill, was published March 30 in the American Journal of Gastroenterology. Researchers say they found that the use of Accutane increased the risk of developing ulcerative colitis by a factor of four.
Researchers looked at data from 87 health insurance plans and found nearly 8,200 people who had been diagnosed with inflammatory bowel disease (IBD), that includes ulcerative colitis and Crohn’s disease.
Researchers found that those taking Accutane were four times more likely to develop ulcerative colitis, and they also determined that the chance of developing the bowel disorder increased in relation to the Accutane dosage, strengthening the evidence of a causal relationship.
Continue reading